Bronstein, Gewirtz & Grossman, LLC encourages investors to seek compensation for alleged misconduct

NEW YORK, NY / ACCESSWIRE / May 12, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Treace Medical Concepts, Inc. (“Treace” or “the Company”) (NASDAQ:TMCI). Investors who purchased Treace securities are encouraged to obtain additional information and assist in the investigation by visiting the Company’s website: bgandg.com/TMCI.

Examination details:

On May 7, 2024, Treace issued a press release with financial results for the first quarter of 2024. Among other things, Treace issued a “revised full-year 2024 guidance range” and expects revenue of $201 million to $211 million from $220 million to $225 million(.)” Explaining the revised guidance, Treace’s CEO cited “increased use of MIS osteotomy solutions and increased competition from imitations of our Lapiplasty® products.” JP Morgan subsequently downgraded Treace, citing appeal downplayed the revised forecasts, noting that there is a lack of clarity about how much market share Treace can regain when competing with larger orthopedic rivals. On this news, Treace’s stock price fell $6.95 per share, or 62.5%, to close at $4.17 per share on May 8, 2024.

What’s next?

If you are aware of any facts relating to this investigation or the Treace securities purchased, you may assist in this investigation by visiting the Company’s website: bgandg.com/TMCI. You may also contact Peretz Bronstein or his account representative Nathan Miller of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660.

There are no costs for you

We represent investors in class actions on a contingency fee basis. This means that we will only ask the court to reimburse us for our expenses and attorneys’ fees, usually a percentage of the total recovery, if we are successful.

Why Bronstein, Gewirtz & Grossman:

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm representing investors in securities fraud class actions and shareholder derivative litigation. Our company has recovered hundreds of millions of dollars for investors nationwide.

Lawyer advertising. Previous results do not guarantee similar results.

CONTACT:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Nathan Miller,
332-239-2660 | (email protected)

SOURCE: Bronstein, Gewirtz and Grossman, LLC